{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:29:29Z","timestamp":1789982969316,"version":"4.0.1"},"reference-count":213,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.ejphar.2008.02.090","type":"journal-article","created":{"date-parts":[[2008,3,16]],"date-time":"2008-03-16T11:41:55Z","timestamp":1205667715000},"page":"303-312","source":"Crossref","is-referenced-by-count":107,"title":["Angiotensin-(1\u20137): Pharmacological properties and pharmacotherapeutic perspectives"],"prefix":"10.1016","volume":"585","author":[{"given":"Dilek","family":"Iusuf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Henning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiek H.","family":"van Gilst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton J.M.","family":"Roks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2008.02.090_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1152\/physiolgenomics.2000.2.1.13","article-title":"Inflammation influences vascular remodeling through AT2 receptor expression and signaling","volume":"2","author":"Akishita","year":"2000","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.ejphar.2008.02.090_bib2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1590\/S0100-879X2000000600012","article-title":"Angiotensin-(1\u20137) potentiates the coronary vasodilatatory effect of bradykinin in the isolated rat heart","volume":"33","author":"Almeida","year":"2000","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.ejphar.2008.02.090_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0167-4889(91)90248-V","article-title":"The mas oncogene enhances angiotensin-induced [Ca2+]i responses in cells with pre-existing angiotensin II receptors","volume":"1133","author":"Ambroz","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2008.02.090_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/01.crd.0000195220.62533.c5","article-title":"Chymase: a new pharmacologic target in cardiovascular disease","volume":"14","author":"Bacani","year":"2006","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.ejphar.2008.02.090_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0196-9781(01)00579-4","article-title":"1A-779 attenuates angiotensin-(1\u20137) depressor response in salt-induced hypertensive rats","volume":"23","author":"Bayorh","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2008.02.090_bib6","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/01.HYP.26.6.1138","article-title":"Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin-(1\u20137)","volume":"26","author":"Benter","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib7","first-page":"H313","article-title":"Antihypertensive actions of angiotensin-(1\u20137) in spontaneously hypertensive rats","volume":"269","author":"Benter","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib8","doi-asserted-by":"crossref","first-page":"H684","DOI":"10.1152\/ajpheart.00632.2005","article-title":"Angiotensin-(1\u20137) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with l-NAME","volume":"290","author":"Benter","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib9","doi-asserted-by":"crossref","first-page":"H666","DOI":"10.1152\/ajpheart.00372.2006","article-title":"Angiotensin-(1\u20137) prevents diabetes-induced cardiovascular dysfunction","volume":"292","author":"Benter","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000108758","article-title":"Angiotensin-(1\u20137) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats","volume":"28","author":"Benter","year":"2008","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib11","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1161\/01.HYP.26.5.738","article-title":"Chronic angiotensin-converting enzyme inhibition and endothelial function of rat aorta","volume":"26","author":"Berkenboom","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib12","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/00005344-200205000-00015","article-title":"Inhibition of vascular smooth muscle cell growth by angiotensin type 2 receptor stimulation for in vitro organ culture model","volume":"39","author":"Brogelli","year":"2002","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib13","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/01.HYP.27.3.523","article-title":"Angiotensin-(1\u20137) dilates canine coronary arteries through kinins and nitric oxide","volume":"27","author":"Brosnihan","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib14","first-page":"227","article-title":"Angiotensin-(1\u20137): a novel vasodilator of the coronary circulation","volume":"31","author":"Brosnihan","year":"1998","journal-title":"Biol. Res."},{"issue":"Suppl 4","key":"10.1016\/j.ejphar.2008.02.090_bib15","first-page":"1","article-title":"Endothelial mechanisms in vasomotor effects of ACE inhibitors","volume":"83","author":"Busse","year":"1994","journal-title":"Z. Kardiol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib16","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1357-2725(02)00262-5","article-title":"The renin\u2013angiotensin and the kallikrein\u2013kinin systems","volume":"35","author":"Campbell","year":"2003","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/01.HYP.22.4.513","article-title":"Nephrectomy, converting enzyme inhibition, and angiotensin peptides","volume":"22","author":"Campbell","year":"1993","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib18","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1161\/01.HYP.23.4.439","article-title":"Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides","volume":"23","author":"Campbell","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1161\/01.HYP.23.4.439","article-title":"Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides","volume":"23","author":"Campbell","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1161\/01.HYP.23.4.439","article-title":"Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides","volume":"23","author":"Campbell","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/01.CIR.0000021122.63813.32","article-title":"Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice","volume":"106","author":"Candido","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.02.090_bib22","doi-asserted-by":"crossref","first-page":"I66","DOI":"10.1161\/01.HYP.11.2_Pt_2.I66","article-title":"Site of entry of kininase II into renal tubular fluid","volume":"11","author":"Cardini","year":"1988","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib23","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1161\/HYPERTENSIONAHA.107.094987","article-title":"Evidence for Mas-mediated bradykinin potentiation by the angiotensin-(1\u20137) nonpeptide mimic AVE 0991 in normotensive rats","volume":"50","author":"Carvalho","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib24","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1161\/01.HYP.0000175813.04375.8a","article-title":"Evidence for a functional interaction of the angiotensin-(1\u20137) receptor Mas with AT1 and AT2 receptors in the mouse heart","volume":"46","author":"Castro","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.lfs.2006.09.007","article-title":"Effects of genetic deletion of angiotensin-(1\u20137) receptor Mas on cardiac function during ischemia\/reperfusion in the isolated perfused mouse heart","volume":"80","author":"Castro","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2008.02.090_bib26","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.lfs.2006.09.007","article-title":"Effects of genetic deletion of angiotensin-(1\u20137) receptor Mas on cardiac function during ischemia\/reperfusion in the isolated perfused mouse heart","volume":"80","author":"Castro","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2008.02.090_bib27","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/HYPERTENSIONAHA.106.076216","article-title":"Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1\u20137)-MAS receptor axis: more than regulation of blood pressure?","volume":"50","author":"Chappell","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib28","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1590\/S0100-879X1998000900014","article-title":"Antihypertensive effects of angiotensin-(1\u20137)","volume":"31","author":"Chappell","year":"1998","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.ejphar.2008.02.090_bib29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1161\/01.HYP.31.1.362","article-title":"Metabolism of angiotensin-(1\u20137) by angiotensin-converting enzyme","volume":"31","author":"Chappell","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib30","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0196-9781(95)00044-K","article-title":"Characterization of angiotensin II receptor subtypes in pancreatic acinar AR42J cells","volume":"16","author":"Chappell","year":"1995","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2008.02.090_bib31","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.HYP.37.4.1141","article-title":"Angiotensin-(1\u20137) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells","volume":"37","author":"Clark","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib32","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00005344-200104000-00011","article-title":"Downregulation of the AT1A receptor by pharmacologic concentrations of angiotensin-(1\u20137)","volume":"37","author":"Clark","year":"2001","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib33","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00005344-200302000-00017","article-title":"Angiotensin-(1\u20137) reduces renal angiotensin II receptors through a cyclooxygenase-dependent mechanism","volume":"41","author":"Clark","year":"2003","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib34","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3317\/jraas.2003.028","article-title":"The role of Ang (1\u20137) in mediating the chronic hypotensive effects of losartan in normal rats","volume":"4","author":"Collister","year":"2003","journal-title":"J. Renin\u2013Angiotensin\u2013Aldosterone Syst."},{"key":"10.1016\/j.ejphar.2008.02.090_bib35","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2008.02.090_bib36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3317\/jraas.2004.041","article-title":"Angiotensin (1\u20137) re-establishes impulse conduction in cardiac muscle during ischaemia-reperfusion. The role of the sodium pump","volume":"5","author":"De Mello","year":"2004","journal-title":"J. Renin\u2013Angiotensin\u2013Aldosterone Syst."},{"key":"10.1016\/j.ejphar.2008.02.090_bib37","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/01.HYP.31.4.912","article-title":"N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1\u20137) and keto-ACE","volume":"31","author":"Deddish","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib38","first-page":"371","article-title":"Hypotensive function of the brain angiotensin-(1\u20137) in Sprague Dawley and renin transgenic rats","volume":"54","author":"Dobruch","year":"2003","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib39","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2008.02.090_bib40","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/00005344-199612000-00003","article-title":"Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction","volume":"28","author":"Duncan","year":"1996","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib41","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0196-9781(01)00404-1","article-title":"Gender differences in the attenuation of salt-induced hypertension by angiotensin (1\u20137)","volume":"22","author":"Eatman","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2008.02.090_bib42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00280-003-0710-0","article-title":"Synergistic effects of co-administration of angiotensin 1\u20137 and Neupogen on hematopoietic recovery in mice","volume":"53","author":"Ellefson","year":"2004","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib43","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/01.HYP.0000174594.17052.33","article-title":"Short-term angiotensin(1\u20137) receptor MAS stimulation improves endothelial function in normotensive rats","volume":"46","author":"Faria-Silva","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib44","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/01.HYP.37.2.703","article-title":"Potentiation of bradykinin by angiotensin-(1\u20137) on arterioles of spontaneously hypertensive rats studied in vivo","volume":"37","author":"Fernandes","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib45","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/01.HYP.0000196268.08909.fb","article-title":"Angiotensin-converting enzyme 2 and angiotensin-(1\u20137): an evolving story in cardiovascular regulation","volume":"47","author":"Ferrario","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib46","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3949\/ccjm.56.4.439","article-title":"The renin angiotensin system: importance in physiology and pathology","volume":"56","author":"Ferrario","year":"1989","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.ejphar.2008.02.090_bib47","doi-asserted-by":"crossref","first-page":"IV56","DOI":"10.1002\/clc.4960141809","article-title":"Hypertensive mechanisms and converting enzyme inhibitors","volume":"14","author":"Ferrario","year":"1991","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib48","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0895-7061(02)02268-9","article-title":"Effects of omapatrilat on the renin\u2013angiotensin system in salt-sensitive hypertension","volume":"15","author":"Ferrario","year":"2002","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejphar.2008.02.090_bib49","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.lfs.2007.07.022","article-title":"Isoproterenol-induced impairment of heart function and remodeling are attenuated by the nonpeptide angiotensin-(1\u20137) analogue AVE 0991","volume":"81","author":"Ferreira","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2008.02.090_bib50","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.regpep.2006.06.005","article-title":"Renal function in transgenic rats expressing an angiotensin-(1\u20137)-producing fusion protein","volume":"137","author":"Ferreira","year":"2006","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2008.02.090_bib51","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1161\/01.HYP.38.3.665","article-title":"Angiotensin-(1\u20137): cardioprotective effect in myocardial ischemia\/reperfusion","volume":"38","author":"Ferreira","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib52","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1590\/S0100-879X2002000900009","article-title":"Angiotensin-(1\u20137) improves the post-ischemic function in isolated perfused rat hearts","volume":"35","author":"Ferreira","year":"2002","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.ejphar.2008.02.090_bib53","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0006-8993(00)02482-3","article-title":"Angiotensin-(1\u20137) causes endothelium-dependent relaxation in canine middle cerebral artery","volume":"873","author":"Feterik","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2008.02.090_bib54","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0008-6363(99)00094-2","article-title":"Signal transduction of eNOS activation","volume":"43","author":"Fleming","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2008.02.090_bib55","doi-asserted-by":"crossref","first-page":"E68","DOI":"10.1161\/hh1101.092677","article-title":"Phosphorylation of Thr(495) regulates Ca(2+)\/calmodulin-dependent endothelial nitric oxide synthase activity","volume":"88","author":"Fleming","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2008.02.090_bib56","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0006-8993(94)91171-1","article-title":"Evidence that angiotensin-(1\u20137) plays a role in the central control of blood pressure at the ventro-lateral medulla acting through specific receptors","volume":"665","author":"Fontes","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2008.02.090_bib57","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/01.HYP.28.1.104","article-title":"Angiotensin-(1\u20137) inhibits vascular smooth muscle cell growth","volume":"28","author":"Freeman","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib58","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2174\/138161280406221011112056","article-title":"Chymase: its pathophysiological roles and inhibitors","volume":"4","author":"Fukami","year":"1998","journal-title":"Curr. Pharm. Des"},{"key":"10.1016\/j.ejphar.2008.02.090_bib59","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/carcin\/bgh236","article-title":"Inhibition of human lung cancer cell growth by angiotensin-(1\u20137)","volume":"25","author":"Gallagher","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejphar.2008.02.090_bib60","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1681\/ASN.V541133","article-title":"Angiotensin 1\u20137 has a biphasic effect on fluid absorption in the proximal straight tubule","volume":"5","author":"Garcia","year":"1994","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib61","doi-asserted-by":"crossref","first-page":"H1154","DOI":"10.1152\/ajpheart.01395.2006","article-title":"Angiotensin-(1\u20137) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors","volume":"293","author":"Giani","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib62","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0167-0115(99)00067-1","article-title":"Angiotensin-(1\u20137) binds at the type 1 angiotensin II receptors in rat renal cortex","volume":"84","author":"Gironacci","year":"1999","journal-title":"Regul.Pept."},{"key":"10.1016\/j.ejphar.2008.02.090_bib63","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/01.HYP.23.4.411","article-title":"Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin","volume":"23","author":"Gohlke","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib64","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/01.CIR.0000156466.02908.ED","article-title":"Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients","volume":"111","author":"Gradman","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.02.090_bib65","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1139\/y06-053","article-title":"Angiotensin-(1\u20137) potentiates responses to bradykinin but does not change responses to angiotensin I","volume":"84","author":"Greco","year":"2006","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib66","doi-asserted-by":"crossref","first-page":"H736","DOI":"10.1152\/ajpheart.00937.2006","article-title":"Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1\u20137)","volume":"292","author":"Grobe","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib67","doi-asserted-by":"crossref","first-page":"H2417","DOI":"10.1152\/ajpheart.01170.2005","article-title":"Chronic angiotensin-(1\u20137) prevents cardiac fibrosis in DOCA\u2013salt model of hypertension","volume":"290","author":"Grobe","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib68","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1681\/ASN.V1181377","article-title":"Metabolism alters the selectivity of angiotensin-(1\u20137) receptor ligands for angiotensin receptors","volume":"11","author":"Handa","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib69","first-page":"F141","article-title":"Renal actions of angiotensin-(1\u20137): in vivo and in vitro studies","volume":"270","author":"Handa","year":"1996","journal-title":"Am. J. Physiol"},{"key":"10.1016\/j.ejphar.2008.02.090_bib70","doi-asserted-by":"crossref","first-page":"16587","DOI":"10.1074\/jbc.M100229200","article-title":"Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation","volume":"276","author":"Harris","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.02.090_bib71","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1081\/CEH-200057421","article-title":"Efficacy of combination antihypertensive therapy with low-dose indapamide: assessment by blood pressure self-monitoring at home","volume":"27","author":"Hashimoto","year":"2005","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.ejphar.2008.02.090_bib72","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1113\/expphysiol.2005.031096","article-title":"Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats","volume":"90","author":"Huentelman","year":"2005","journal-title":"Exp. Physiol"},{"key":"10.1016\/j.ejphar.2008.02.090_bib73","doi-asserted-by":"crossref","first-page":"H2356","DOI":"10.1152\/ajpheart.00317.2005","article-title":"Angiotensin-(1\u20137) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects","volume":"289","author":"Iwata","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib74","doi-asserted-by":"crossref","first-page":"H2356","DOI":"10.1152\/ajpheart.00317.2005","article-title":"Angiotensin-(1\u20137) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects","volume":"289","author":"Iwata","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib75","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/01.HYP.36.3.417","article-title":"Contribution of angiotensin-(1\u20137) to blood pressure regulation in salt-depleted hypertensive rats","volume":"36","author":"Iyer","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib76","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/01.HYP.31.2.699","article-title":"Vasodepressor actions of angiotensin-(1\u20137) unmasked during combined treatment with lisinopril and losartan","volume":"31","author":"Iyer","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib77","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/00005344-199803000-00019","article-title":"Role of AT1 and AT2 receptors in the plasma clearance of angiotensin II","volume":"31","author":"Iyer","year":"1998","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib78","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00005344-200007000-00015","article-title":"Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1\u20137) during chronic blockade of the renin\u2013angiotensin system","volume":"36","author":"Iyer","year":"2000","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib79","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/335437a0","article-title":"The mas oncogene encodes an angiotensin receptor","volume":"335","author":"Jackson","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2008.02.090_bib80","doi-asserted-by":"crossref","first-page":"II49","DOI":"10.1161\/01.HYP.19.2_Suppl.II49","article-title":"Stimulation of endothelial cell prostaglandin production by angiotensin peptides. Characterization of receptors","volume":"19","author":"Jaiswal","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib81","first-page":"664","article-title":"Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved","volume":"265","author":"Jaiswal","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2008.02.090_bib82","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ahj.2006.01.009","article-title":"Rationale and design: the VALsartan In Diastolic Dysfunction (VALIDD) Trial: evolving the management of diastolic dysfunction in hypertension","volume":"152","author":"Janardhanan","year":"2006","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejphar.2008.02.090_bib83","doi-asserted-by":"crossref","first-page":"12827","DOI":"10.1021\/bi050805p","article-title":"Post-translational modification of therapeutic peptides by NisB, the dehydratase of the lantibiotic nisin","volume":"44","author":"Kluskens","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2008.02.090_bib84","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/01.CIR.95.6.1455","volume":"95","author":"Kokkonen","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.02.090_bib85","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11892-001-0043-5","article-title":"Treatment of hypertension in diabetic patients with nephropathy","volume":"1","author":"Komers","year":"2001","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.ejphar.2008.02.090_bib86","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/0024-3205(86)90565-5","article-title":"Biological activities of angiotensin II-(1\u20136)-hexapeptide and angiotensin II-(1\u20137)-heptapeptide in man","volume":"38","author":"Kono","year":"1986","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2008.02.090_bib87","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1742-7843.2007.00057.x","article-title":"On the mechanism of coronary vasodilation induced by angiotensin-(1\u20137) in the isolated guinea pig heart","volume":"100","author":"Kozlovski","year":"2007","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib88","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3317\/jraas.2000.041","article-title":"The antithrombotic effect of angiotensin-(1\u20137) closely resembles that of losartan","volume":"1","author":"Kucharewicz","year":"2000","journal-title":"J. Renin\u2013Angiotensin\u2013Aldosterone Syst."},{"key":"10.1016\/j.ejphar.2008.02.090_bib89","doi-asserted-by":"crossref","first-page":"19087","DOI":"10.1074\/jbc.M200258200","article-title":"Disabling a C-terminal autoinhibitory control element in endothelial nitric-oxide synthase by phosphorylation provides a molecular explanation for activation of vascular NO synthesis by diverse physiological stimuli","volume":"277","author":"Lane","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.02.090_bib90","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/01.HYP.0000149382.83973.c2","article-title":"Angiotensin-(1\u20137) attenuates neointimal formation after stent implantation in the rat","volume":"45","author":"Langeveld","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib91","first-page":"157","article-title":"The renin system in essential, renovascular and adrenocortical hypertension: an overview","volume":"7","author":"Laragh","year":"1977","journal-title":"Adv. Nephrol. Necker Hosp."},{"key":"10.1016\/j.ejphar.2008.02.090_bib92","first-page":"1781","article-title":"Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade","volume":"36","author":"Laragh","year":"1977","journal-title":"Fed. Proc."},{"key":"10.1016\/j.ejphar.2008.02.090_bib93","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/00005344-199711000-00019","article-title":"Angiotensin-(1\u20137) and the rat aorta: modulation by the endothelium","volume":"30","author":"le","year":"1997","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib94","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/01.fjc.0000175237.41573.63","article-title":"The endothelium-dependent vasodilator effect of the nonpeptide Ang(1\u20137) mimic AVE 0991 is abolished in the aorta of mas-knockout mice","volume":"46","author":"Lemos","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib95","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0002-9440(10)65037-7","article-title":"Up-regulation of AT(1) and AT(2) receptors in postinfarcted hypertrophied myocytes and stretch-mediated apoptotic cell death","volume":"156","author":"Leri","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib96","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1053\/ajkd.2001.27442","article-title":"A clinical trial in type 2 diabetic nephropathy","volume":"38","author":"Lewis","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ejphar.2008.02.090_bib97","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1161\/01.HYP.29.1.394","article-title":"Angiotensin-(1\u20137) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide","volume":"29","author":"Li","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib98","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2174\/1568026023394209","article-title":"Cyclization strategies in peptide derived drug design","volume":"2","author":"Li","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejphar.2008.02.090_bib99","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1463-1326.2006.00623.x","article-title":"Angiotensin receptor antagonist vs. angiotensin-converting enzyme inhibitor in Asian subjects with type 2 diabetes and albuminuria \u2014 a randomized crossover study","volume":"9","author":"Lim","year":"2007","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ejphar.2008.02.090_bib100","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/01.HYP.30.3.542","article-title":"Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1\u20137) in normotensive and hypertensive rats","volume":"30","author":"Lima","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib101","doi-asserted-by":"crossref","first-page":"44719","DOI":"10.1074\/jbc.M302836200","article-title":"Phosphorylation of threonine 497 in endothelial nitric-oxide synthase coordinates the coupling of l-arginine metabolism to efficient nitric oxide production","volume":"278","author":"Lin","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.02.090_bib102","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1161\/01.CIR.0000013847.07035.B9","article-title":"Angiotensin-(1\u20137) attenuates the development of heart failure after myocardial infarction in rats","volume":"105","author":"Loot","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.02.090_bib103","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/00004872-199606000-00017","article-title":"Effects of captopril related to increased levels of prostacyclin and angiotensin-(1\u20137) in essential hypertension","volume":"14","author":"Luque","year":"1996","journal-title":"J. Hypertens."},{"issue":"Suppl 1","key":"10.1016\/j.ejphar.2008.02.090_bib104","doi-asserted-by":"crossref","first-page":"21S","DOI":"10.1111\/j.1365-2125.1987.tb03119.x","article-title":"The importance of the response of the renin\u2013angiotensin system in determining blood pressure changes with sodium restriction","volume":"23","author":"MacGregor","year":"1987","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib105","doi-asserted-by":"crossref","first-page":"R994","DOI":"10.1152\/ajpregu.2001.280.4.R994","article-title":"Mechanisms of angiotensin-(1\u20137)-induced inhibition of angiogenesis","volume":"280","author":"Machado","year":"2001","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib106","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/00004872-199412000-00010","article-title":"Angiotensin(1\u20137) is an antagonist at the type 1 angiotensin II receptor","volume":"12","author":"Mahon","year":"1994","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2008.02.090_bib107","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00005344-200405000-00011","article-title":"Angiotensin-(1\u20137) antagonist A-779 attenuates the potentiation of bradykinin by captopril in rats","volume":"43","author":"Maia","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib108","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archinte.1994.00420050059006","article-title":"Angiotensin-converting enzyme inhibitors in hypertension. A dozen years of experience","volume":"154","author":"Materson","year":"1994","journal-title":"Arch.Intern.Med."},{"key":"10.1016\/j.ejphar.2008.02.090_bib109","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJM199304013281303","article-title":"Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents","volume":"328","author":"Materson","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2008.02.090_bib110","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/jb\/mvg099","article-title":"Regulation of endothelial nitric oxide synthase by protein kinase C","volume":"133","author":"Matsubara","year":"2003","journal-title":"J. Biochem. (Tokyo)"},{"key":"10.1016\/j.ejphar.2008.02.090_bib111","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0735-1097(00)00741-5","article-title":"The clinical, cardiac, renal, arterial and neurohormonal effects of omapatrilat, a vasopeptidase inhibitor, in patients with chronic heart failure","volume":"36","author":"McClean","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib112","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.regpep.2004.07.023","article-title":"Chronic infusion of angiotensin-(1\u20137) reduces heart angiotensin II levels in rats","volume":"125","author":"Mendes","year":"2005","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2008.02.090_bib113","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1158\/0008-5472.CAN-06-3614","article-title":"Angiotensin-(1\u20137) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2","volume":"67","author":"Menon","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2008.02.090_bib114","doi-asserted-by":"crossref","first-page":"17625","DOI":"10.1074\/jbc.C100122200","article-title":"Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase","volume":"276","author":"Michell","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.02.090_bib115","doi-asserted-by":"crossref","first-page":"132A","DOI":"10.1016\/S0002-9149(97)00468-2","article-title":"Angiotensin I-converting enzyme inhibitors potentiate bradykinin's inotropic effects independently of blocking its inactivation","volume":"80","author":"Minshall","year":"1997","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib116","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1161\/01.RES.81.5.848","article-title":"Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells","volume":"81","author":"Minshall","year":"1997","journal-title":"Circ.Res."},{"key":"10.1016\/j.ejphar.2008.02.090_bib117","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.yjmcc.2006.05.023","article-title":"Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation","volume":"42","author":"Mount","year":"2007","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib118","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0022-3565(24)37208-8","article-title":"Signal transduction mechanisms involved in angiotensin-(1\u20137)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells","volume":"284","author":"Muthalif","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2008.02.090_bib119","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bbrc.2006.09.146","article-title":"Isolation and identification of proangiotensin-12, a possible component of the renin\u2013angiotensin system","volume":"350","author":"Nagata","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2008.02.090_bib120","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bbrc.2006.09.146","article-title":"Isolation and identification of proangiotensin-12, a possible component of the renin\u2013angiotensin system","volume":"350","author":"Nagata","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2008.02.090_bib121","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/jama.1993.03510060059034","article-title":"Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group","volume":"270","author":"Neaton","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2008.02.090_bib122","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0167-0115(00)00164-6","article-title":"Angiotensin-(1\u20137) regulates the levels of angiotensin II receptor subtype AT1 mRNA differentially in a strain-specific fashion","volume":"95","author":"Neves","year":"2000","journal-title":"Regul.Pept."},{"key":"10.1016\/j.ejphar.2008.02.090_bib123","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1126\/science.191908","article-title":"Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents","volume":"196","author":"Ondetti","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2008.02.090_bib124","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0140-6736(07)61508-6","article-title":"Dual inhibition of the rennin system by aliskiren and valsartan","volume":"370","author":"Oparil","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2008.02.090_bib125","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1161\/01.HYP.26.6.1154","article-title":"Angiotensin-(1\u20137) potentiates the hypotensive effect of bradykinin in conscious rats","volume":"26","author":"Paula","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib126","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1161\/01.HYP.26.6.1154","article-title":"Angiotensin-(1\u20137) potentiates the hypotensive effect of bradykinin in conscious rats","volume":"26","author":"Paula","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib127","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1161\/01.HYP.26.6.1154","article-title":"Angiotensin-(1\u20137) potentiates the hypotensive effect of bradykinin in conscious rats","volume":"26","author":"Paula","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib128","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1152\/physrev.1977.57.2.313","article-title":"Renin\u2013angiotensin system: biochemistry and mechanisms of action","volume":"57","author":"Peach","year":"1977","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2008.02.090_bib129","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1097\/HJH.0b013e3282f0143c","article-title":"Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function","volume":"25","author":"Peiro","year":"2007","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2008.02.090_bib130","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/01.HYP.0000141438.64887.42","article-title":"Nonpeptide AVE 0991 is an angiotensin-(1\u20137) receptor Mas agonist in the mouse kidney","volume":"44","author":"Pinheiro","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.18553\/jmcp.2007.13.s8-b.21","article-title":"Direct renin inhibition: focus on aliskiren","volume":"13","author":"Pool","year":"2007","journal-title":"J. Manag. Care Pharm."},{"key":"10.1016\/j.ejphar.2008.02.090_bib132","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.amjhyper.2006.06.003","article-title":"Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan","volume":"20","author":"Pool","year":"2007","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejphar.2008.02.090_bib133","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1476-5381.1994.tb14787.x","article-title":"Release of nitric oxide by angiotensin-(1\u20137) from porcine coronary endothelium: implications for a novel angiotensin receptor","volume":"111","author":"Porsti","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib134","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/00004872-200205000-00025","article-title":"Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE\/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate\u2013salt hypertensive rats","volume":"20","author":"Pu","year":"2002","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2008.02.090_bib135","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1074-5521(00)00134-4","article-title":"Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin","volume":"7","author":"Rahuel","year":"2000","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib136","first-page":"703","article-title":"The importance of ACE2 in regulating the cardiovascular system","volume":"146","author":"Raz","year":"2007","journal-title":"Harefuah"},{"key":"10.1016\/j.ejphar.2008.02.090_bib137","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/01.HYP.0000209020.69734.73","article-title":"A place in our hearts for the lowly angiotensin 1\u20137 peptide?","volume":"47","author":"Reudelhuber","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib138","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/BJ20040634","article-title":"Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism","volume":"383","author":"Rice","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2008.02.090_bib139","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1345\/aph.1E327","article-title":"Valsartan in chronic heart failure","volume":"39","author":"Ripley","year":"2005","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejphar.2008.02.090_bib140","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1743-6109.2006.00124.x","article-title":"Expression of intracellular filament, collagen, and collagenase genes in diabetic and normal skin after injury","volume":"14","author":"Rodgers","year":"2006","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.ejphar.2008.02.090_bib141","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00280-005-0078-4","article-title":"Phase I\/II dose escalation study of angiotensin 1\u20137 [A(1\u20137)] administered before and after chemotherapy in patients with newly diagnosed breast cancer","volume":"57","author":"Rodgers","year":"2006","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib142","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00280-005-0078-4","article-title":"Phase I\/II dose escalation study of angiotensin 1\u20137 [A(1\u20137)] administered before and after chemotherapy in patients with newly diagnosed breast cancer","volume":"57","author":"Rodgers","year":"2006","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib143","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/01.PRS.0000047403.23105.66","article-title":"Acceleration of healing, reduction of fibrotic scar, and normalization of tissue architecture by an angiotensin analogue, NorLeu3-A(1\u20137)","volume":"111","author":"Rodgers","year":"2003","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.ejphar.2008.02.090_bib144","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00280-002-0434-6","article-title":"Accelerated recovery from irradiation injury by angiotensin peptides","volume":"49","author":"Rodgers","year":"2002","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib145","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1097\/00004872-200412000-00018","article-title":"Low sodium diet inhibits the local counter-regulator effect of angiotensin-(1\u20137) on angiotensin II","volume":"22","author":"Roks","year":"2004","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2008.02.090_bib146","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0008-6363(97)00173-9","article-title":"Vectors based on Semliki Forest virus for rapid and efficient gene transfer into non-endothelial cardiovascular cells: comparison to adenovirus","volume":"35","author":"Roks","year":"1997","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2008.02.090_bib147","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/01.HYP.34.2.296","article-title":"Angiotensin-(1\u20137) is a modulator of the human renin\u2013angiotensin system","volume":"34","author":"Roks","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib148","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0167-0115(95)00010-9","article-title":"Angiotensin-(1\u20137) binding at angiotensin II receptors in the rat brain","volume":"56","author":"Rowe","year":"1995","journal-title":"Regul.Pept."},{"key":"10.1016\/j.ejphar.2008.02.090_bib149","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.semnephrol.2003.11.002","article-title":"Angiotensin-converting enzyme inhibition and angiotensin II antagonism in nondiabetic chronic nephropathies","volume":"24","author":"Ruggenenti","year":"2004","journal-title":"Semin.Nephrol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib150","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1681\/ASN.V12122832","article-title":"ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy","volume":"12","author":"Ruggenenti","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib151","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1161\/HYPERTENSIONAHA.106.084848","article-title":"Angiotensin-(1\u20137) counterregulates angiotensin II signaling in human endothelial cells","volume":"50","author":"Sampaio","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib152","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/01.CIR.53.3.400","article-title":"The role of the renin\u2013angiotensin\u2013aldosterone system in cardiovascular homeostasis in normal human subjects","volume":"53","author":"Sancho","year":"1976","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.02.090_bib153","first-page":"1033","article-title":"Central and peripheral actions of angiotensin-(1\u20137)","volume":"27","author":"Santos","year":"1994","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.ejphar.2008.02.090_bib154","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1527-3466.2006.00239.x","article-title":"Pharmacological effects of AVE 0991, a nonpeptide angiotensin-(1\u20137) receptor agonist","volume":"24","author":"Santos","year":"2006","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.ejphar.2008.02.090_bib155","doi-asserted-by":"crossref","first-page":"I153","DOI":"10.1161\/01.HYP.11.2_Pt_2.I153","article-title":"Converting enzyme activity and angiotensin metabolism in the dog brainstem","volume":"11","author":"Santos","year":"1988","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib156","doi-asserted-by":"crossref","first-page":"II56","DOI":"10.1161\/01.HYP.19.2_Suppl.II56","article-title":"Production of angiotensin-(1\u20137) by human vascular endothelium","volume":"19","author":"Santos","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib157","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0167-0115(00)00138-5","article-title":"Angiotensin-(1\u20137): an update","volume":"91","author":"Santos","year":"2000","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2008.02.090_bib158","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0361-9230(94)90104-X","article-title":"Characterization of a new angiotensin antagonist selective for angiotensin-(1\u20137): evidence that the actions of angiotensin-(1\u20137) are mediated by specific angiotensin receptors","volume":"35","author":"Santos","year":"1994","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2008.02.090_bib159","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/01.HYP.0000215289.51180.5c","article-title":"Impairment of in vitro and in vivo heart function in angiotensin-(1\u20137) receptor MAS knockout mice","volume":"47","author":"Santos","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib160","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1152\/physiolgenomics.00227.2003","article-title":"Expression of an angiotensin-(1\u20137)-producing fusion protein produces cardioprotective effects in rats","volume":"17","author":"Santos","year":"2004","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.ejphar.2008.02.090_bib161","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2174\/156801605774322373","article-title":"Angiotensin-(1\u20137): blood, heart, and blood vessels","volume":"3","author":"Santos","year":"2005","journal-title":"Curr. Med. Chem. Cardiovasc. Hematol. Agents"},{"key":"10.1016\/j.ejphar.2008.02.090_bib162","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/01.HYP.0000052947.60363.24","article-title":"Characterization of a new selective antagonist for angiotensin-(1\u20137), d-pro7-angiotensin-(1\u20137)","volume":"41","author":"Santos","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib163","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1\u20137) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl 9","key":"10.1016\/j.ejphar.2008.02.090_bib164","first-page":"IX\/70","article-title":"Atherosclerosis-associated endothelial dysfunction","volume":"89","author":"Schachinger","year":"2000","journal-title":"Z. Kardiol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib165","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1073\/pnas.85.11.4095","article-title":"Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1\u20137) heptapeptide","volume":"85","author":"Schiavone","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2008.02.090_bib166","first-page":"125","article-title":"Role of the vasodilator peptide angiotensin-(1\u20137) in cardiovascular drug therapy","volume":"3","author":"Schindler","year":"2007","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.ejphar.2008.02.090_bib167","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1152\/ajpregu.00535.2002","article-title":"The kallikrein\u2013kinin and the renin\u2013angiotensin systems have a multilayered interaction","volume":"285","author":"Schmaier","year":"2003","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib168","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/01.hjh.0000166826.17570.86","article-title":"Optimizing therapeutic strategies to achieve renal and cardiovascular risk reduction in diabetic patients with angiotensin receptor blockers","volume":"23","author":"Schmieder","year":"2005","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2008.02.090_bib169","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.2337\/dc06-1551","article-title":"Impact of telmisartan versus ramipril on renal endothelial function in patients with hypertension and type 2 diabetes","volume":"30","author":"Schmieder","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2008.02.090_bib170","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1055\/s-2006-956273","article-title":"Subclinical albuminuria, microalbuminuria and proteinuria-accepted cardiovascular risk markers?","volume":"131","author":"Schmieder","year":"2006","journal-title":"Dtsch. Med. Wochenschr."},{"key":"10.1016\/j.ejphar.2008.02.090_bib171","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.amjhyper.2007.04.001","article-title":"Aliskiren, the first renin inhibitor for treating hypertension: reactive renin secretion may limit its effectiveness","volume":"20","author":"Sealey","year":"2007","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejphar.2008.02.090_bib172","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/01.RES.39.5.671","article-title":"Angiotensin II and its heptapeptide (2\u20138), hexapeptide (3\u20138), and pentapeptide (4\u20138) metabolites in arterial and venous blood of man","volume":"39","author":"Semple","year":"1976","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2008.02.090_bib173","first-page":"S169","article-title":"Renin, angiotensin II and III in acute renal failure: note on the measurement of angiotensin II and III in rat blood","volume":"6","author":"Semple","year":"1976","journal-title":"Kidney Int. Suppl"},{"key":"10.1016\/j.ejphar.2008.02.090_bib174","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1161\/01.RES.38.6.122","article-title":"Angiotensin II and angiotensin III in rat blood","volume":"38","author":"Semple","year":"1976","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2008.02.090_bib175","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.peptides.2006.10.007","article-title":"Evidence for a new angiotensin-(1\u20137) receptor subtype in the aorta of Sprague\u2013Dawley rats","volume":"28","author":"Silva","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2008.02.090_bib176","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2003.12.010","article-title":"Site-specific microinjection of liposomes into the brain for local infusion of a short-lived peptide","volume":"95","author":"Silva-Barcellos","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejphar.2008.02.090_bib177","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/hy1201.096056","article-title":"Long-lasting cardiovascular effects of liposome-entrapped angiotensin-(1\u20137) at the rostral ventrolateral medulla","volume":"38","author":"Silva-Barcellos","year":"2001","journal-title":"Hypertension"},{"issue":"Suppl 1","key":"10.1016\/j.ejphar.2008.02.090_bib178","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1007\/s00592-005-0181-3","article-title":"The ONTARGET\/TRANSCEND Trial Programme: baseline data","volume":"42","author":"Sleight","year":"2005","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib179","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3317\/jraas.2000.001","article-title":"Novel mechanisms linking angiotensin II and early atherogenesis","volume":"1","author":"Strawn","year":"2000","journal-title":"J. Renin\u2013Angiotensin\u2013Aldosterone Syst."},{"key":"10.1016\/j.ejphar.2008.02.090_bib180","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.HYP.33.1.207","article-title":"Angiotensin-(1\u20137) reduces smooth muscle growth after vascular injury","volume":"33","author":"Strawn","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib181","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1124\/jpet.103.064105","article-title":"The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat","volume":"309","author":"Sulpizio","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2008.02.090_bib182","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.tips.2004.08.007","article-title":"Chymase as a novel target for the prevention of vascular diseases","volume":"25","author":"Takai","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2008.02.090_bib183","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/01.HYP.0000090322.55782.30","article-title":"Molecular mechanisms of inhibition of vascular growth by angiotensin-(1\u20137)","volume":"42","author":"Tallant","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib184","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/01.HYP.34.4.950","article-title":"State-of-the-art lecture. Antiproliferative actions of angiotensin-(1\u20137) in vascular smooth muscle","volume":"34","author":"Tallant","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib185","doi-asserted-by":"crossref","first-page":"H1560","DOI":"10.1152\/ajpheart.00941.2004","article-title":"Angiotensin-(1\u20137) inhibits growth of cardiac myocytes through activation of the mas receptor","volume":"289","author":"Tallant","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib186","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/01.HYP.29.1.388","article-title":"Bovine aortic endothelial cells contain an angiotensin-(1\u20137) receptor","volume":"29","author":"Tallant","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib187","doi-asserted-by":"crossref","first-page":"16631","DOI":"10.1016\/S0021-9258(19)85465-0","article-title":"Sequencing and cloning of human prolylcarboxypeptidase (angiotensinase C). Similarity to both serine carboxypeptidase and prolylendopeptidase families","volume":"268","author":"Tan","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.02.090_bib188","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ahj.2004.03.020","volume":"148","author":"Teo","year":"2004","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejphar.2008.02.090_bib189","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1074\/jbc.M109107200","article-title":"Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway","volume":"277","author":"Thomas","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.02.090_bib190","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.02.090_bib191","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/01.HYP.38.1.95","article-title":"Bradykinin potentiation by angiotensin-(1\u20137) and ACE inhibitors correlates with A","volume":"38","author":"Tom","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib192","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/00004872-200107000-00014","article-title":"Negative inotropic effect of bradykinin in porcine isolated atrial trabeculae: role of nitric oxide","volume":"19","author":"Tom","year":"2001","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2008.02.090_bib193","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/archinte.1990.00390180019003","article-title":"Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension","volume":"150","author":"Townsend","year":"1990","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ejphar.2008.02.090_bib194","doi-asserted-by":"crossref","first-page":"H3019","DOI":"10.1152\/ajpheart.01198.2006","article-title":"Primary role of angiotensin-converting enzyme-2 in cardiac production of angiotensin-(1\u20137) in transgenic Ren-2 hypertensive rats","volume":"292","author":"Trask","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib195","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1527-3466.2007.00012.x","article-title":"Angiotensin-(1\u20137): pharmacology and new perspectives in cardiovascular treatments","volume":"25","author":"Trask","year":"2007","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.ejphar.2008.02.090_bib196","first-page":"48","article-title":"Microalbuminuria in patients with hypertension and cardiovascular comorbidity, REAL observational study of treatment with Irbesartan\/HCTZ","volume":"148","author":"Tschope","year":"2006","journal-title":"MMW Fortschr. Med."},{"issue":"Suppl 1","key":"10.1016\/j.ejphar.2008.02.090_bib197","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.3317\/jraas.2004.024","article-title":"The role of the renin\u2013angiotensin\u2013aldosterone system in heart failure","volume":"5","author":"Unger","year":"2004","journal-title":"J. Renin\u2013Angiotensin\u2013Aldosterone Syst."},{"key":"10.1016\/j.ejphar.2008.02.090_bib198","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1161\/01.RES.66.4.883","article-title":"Angiotensin II-forming pathways in normal and failing human hearts","volume":"66","author":"Urata","year":"1990","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2008.02.090_bib199","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00005344-199807000-00025","article-title":"[7-d-ALA]-angiotensin 1\u20137 blocks renal actions of angiotensin 1\u20137 in the anesthetized rat","volume":"32","author":"Vallon","year":"1998","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib200","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1097\/01.hjh.0000244945.42169.c0","article-title":"The role of angiotensin(1\u20137) in renal vasculature of the rat","volume":"24","author":"van der Wouden","year":"2006","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2008.02.090_bib201","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.CIR.0000089191.72957.ED","article-title":"Endothelial function testing as a biomarker of vascular disease","volume":"108","author":"Verma","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.02.090_bib202","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.02.090_bib203","doi-asserted-by":"crossref","first-page":"11867","DOI":"10.1074\/jbc.273.19.11867","article-title":"Sustained long term potentiation and anxiety in mice lacking the Mas protooncogene","volume":"273","author":"Walther","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.02.090_bib204","first-page":"633","article-title":"Angiotensin-(1\u20137) modulates fibrinolytic imbalance induced by oxidized low-density lipoprotein in cultured human umbilical vein endothelial cells","volume":"25","author":"Wang","year":"2005","journal-title":"Di Yi. Jun. Yi. Da. Xue. Xue. Bao."},{"key":"10.1016\/j.ejphar.2008.02.090_bib205","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1097\/00004872-200307006-00007","article-title":"The telmisartan programme of research tO show Telmisartan End-organ proteCTION (PROTECTION) programme","volume":"21","author":"Weber","year":"2003","journal-title":"J. Hypertens.Suppl"},{"key":"10.1016\/j.ejphar.2008.02.090_bib206","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/01.HYP.34.4.964","article-title":"Cardiovascular effects of angiotensin-(1\u20137) in conscious spontaneously hypertensive rats","volume":"34","author":"Widdop","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib207","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/01.HYP.0000037979.53963.8F","article-title":"AVE 0991, a nonpeptide mimic of the effects of angiotensin-(1\u20137) on the endothelium","volume":"40","author":"Wiemer","year":"2002","journal-title":"Hypertension"},{"issue":"Suppl 7","key":"10.1016\/j.ejphar.2008.02.090_bib208","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1097\/00005344-198706107-00017","article-title":"Sustained reduction in blood pressure during chronic administration of a renin inhibitor to normotensive marmosets","volume":"10","author":"Wood","year":"1987","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib209","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/01.HYP.32.3.496","article-title":"Converting enzyme determines plasma clearance of angiotensin-(1\u20137)","volume":"32","author":"Yamada","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib210","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/01.HYP.19.6.692","article-title":"In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats","volume":"19","author":"Yamamoto","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.02.090_bib211","first-page":"10","article-title":"After the HOPE Study. ACE inhibitor now for every diabetic patient? Interview by Dr. Dirk Einecke.","volume":"142","author":"Yusuf","year":"2000","journal-title":"MMW Fortschr. Med."},{"key":"10.1016\/j.ejphar.2008.02.090_bib212","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/00005344-200211000-00007","article-title":"Angiotensin-(1\u20137) inhibits angiotensin II-induced signal transduction","volume":"40","author":"Zhu","year":"2002","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.02.090_bib213","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1161\/01.CIR.0000094733.61689.D4","article-title":"Angiotensin-(1\u20137) formation in the intact human heart: in vivo dependence on angiotensin II as substrate","volume":"108","author":"Zisman","year":"2003","journal-title":"Circulation"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908002859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908002859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T03:28:04Z","timestamp":1738121284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299908002859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":213,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0014299908002859"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.02.090","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}